430 related articles for article (PubMed ID: 22001830)
1. Clinical potential of microRNAs in pancreatic ductal adenocarcinoma.
Steele CW; Oien KA; McKay CJ; Jamieson NB
Pancreas; 2011 Nov; 40(8):1165-71. PubMed ID: 22001830
[TBL] [Abstract][Full Text] [Related]
2. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.
Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J
Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma.
Szafranska AE; Davison TS; John J; Cannon T; Sipos B; Maghnouj A; Labourier E; Hahn SA
Oncogene; 2007 Jun; 26(30):4442-52. PubMed ID: 17237814
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm.
Xue Y; Abou Tayoun AN; Abo KM; Pipas JM; Gordon SR; Gardner TB; Barth RJ; Suriawinata AA; Tsongalis GJ
Cancer Genet; 2013 Jun; 206(6):217-21. PubMed ID: 23933230
[TBL] [Abstract][Full Text] [Related]
5. Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma.
Munding JB; Adai AT; Maghnouj A; Urbanik A; Zöllner H; Liffers ST; Chromik AM; Uhl W; Szafranska-Schwarzbach AE; Tannapfel A; Hahn SA
Int J Cancer; 2012 Jul; 131(2):E86-95. PubMed ID: 21953293
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs: novel diagnostic and therapeutic tools for pancreatic ductal adenocarcinoma?
Mardin WA; Mees ST
Ann Surg Oncol; 2009 Nov; 16(11):3183-9. PubMed ID: 19636633
[TBL] [Abstract][Full Text] [Related]
7. miR-186 and 326 predict the prognosis of pancreatic ductal adenocarcinoma and affect the proliferation and migration of cancer cells.
Zhang ZL; Bai ZH; Wang XB; Bai L; Miao F; Pei HH
PLoS One; 2015; 10(3):e0118814. PubMed ID: 25742499
[TBL] [Abstract][Full Text] [Related]
8. Circulating microRNAs in serum of human K-ras oncogene transgenic rats with pancreatic ductal adenocarcinomas.
Yabushita S; Fukamachi K; Tanaka H; Sumida K; Deguchi Y; Sukata T; Kawamura S; Uwagawa S; Suzui M; Tsuda H
Pancreas; 2012 Oct; 41(7):1013-8. PubMed ID: 22513294
[TBL] [Abstract][Full Text] [Related]
9. Expression of microRNA-218 in human pancreatic ductal adenocarcinoma and its correlation with tumor progression and patient survival.
Zhu Z; Xu Y; Du J; Tan J; Jiao H
J Surg Oncol; 2014 Feb; 109(2):89-94. PubMed ID: 24166773
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis.
Nakata K; Ohuchida K; Mizumoto K; Kayashima T; Ikenaga N; Sakai H; Lin C; Fujita H; Otsuka T; Aishima S; Nagai E; Oda Y; Tanaka M
Surgery; 2011 Nov; 150(5):916-22. PubMed ID: 22018284
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-203 expression as a new prognostic marker of pancreatic adenocarcinoma.
Ikenaga N; Ohuchida K; Mizumoto K; Yu J; Kayashima T; Sakai H; Fujita H; Nakata K; Tanaka M
Ann Surg Oncol; 2010 Dec; 17(12):3120-8. PubMed ID: 20652642
[TBL] [Abstract][Full Text] [Related]
12. Changes in miR-143 and miR-21 expression and clinicopathological correlations in pancreatic cancers.
Tavano F; di Mola FF; Piepoli A; Panza A; Copetti M; Burbaci FP; Latiano T; Pellegrini F; Maiello E; Andriulli A; di Sebastiano P
Pancreas; 2012 Nov; 41(8):1280-4. PubMed ID: 22836856
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel genes associated with a poor prognosis in pancreatic ductal adenocarcinoma via a bioinformatics analysis.
Zhou J; Hui X; Mao Y; Fan L
Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31311829
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma.
Xue A; Scarlett CJ; Jackson CJ; Allen BJ; Smith RC
Pancreas; 2008 Mar; 36(2):160-7. PubMed ID: 18376307
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-183 is involved in cell proliferation, survival and poor prognosis in pancreatic ductal adenocarcinoma by regulating Bmi-1.
Zhou L; Zhang WG; Wang DS; Tao KS; Song WJ; Dou KF
Oncol Rep; 2014 Oct; 32(4):1734-40. PubMed ID: 25109303
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and biological significance of microRNA-192 in pancreatic ductal adenocarcinoma.
Zhao C; Zhang J; Zhang S; Yu D; Chen Y; Liu Q; Shi M; Ni C; Zhu M
Oncol Rep; 2013 Jul; 30(1):276-84. PubMed ID: 23612862
[TBL] [Abstract][Full Text] [Related]
17. Toward a better understanding of pancreatic ductal adenocarcinoma: glimmers of hope?
Partensky C
Pancreas; 2013 Jul; 42(5):729-39. PubMed ID: 23648843
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of miR-194 contributes to tumor growth and progression in pancreatic ductal adenocarcinoma.
Zhang J; Zhao CY; Zhang SH; Yu DH; Chen Y; Liu QH; Shi M; Ni CR; Zhu MH
Oncol Rep; 2014 Mar; 31(3):1157-64. PubMed ID: 24398877
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-21 is induced early in pancreatic ductal adenocarcinoma precursor lesions.
du Rieu MC; Torrisani J; Selves J; Al Saati T; Souque A; Dufresne M; Tsongalis GJ; Suriawinata AA; Carrère N; Buscail L; Cordelier P
Clin Chem; 2010 Apr; 56(4):603-12. PubMed ID: 20093556
[TBL] [Abstract][Full Text] [Related]
20. A gene expression signature of epithelial tubulogenesis and a role for ASPM in pancreatic tumor progression.
Wang WY; Hsu CC; Wang TY; Li CR; Hou YC; Chu JM; Lee CT; Liu MS; Su JJ; Jian KY; Huang SS; Jiang SS; Shan YS; Lin PW; Shen YY; Lee MT; Chan TS; Chang CC; Chen CH; Chang IS; Lee YL; Chen LT; Tsai KK
Gastroenterology; 2013 Nov; 145(5):1110-20. PubMed ID: 23896173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
